These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 25691870)
21. Patch-Clamp Recordings of Action Potentials From Human Atrial Myocytes: Optimization Through Dynamic Clamp. Verkerk AO; Marchal GA; Zegers JG; Kawasaki M; Driessen AHG; Remme CA; de Groot JR; Wilders R Front Pharmacol; 2021; 12():649414. PubMed ID: 33912059 [No Abstract] [Full Text] [Related]
22. Required G Fabbri A; Goversen B; Vos MA; van Veen TAB; de Boer TP Biophys J; 2019 Dec; 117(12):2303-2315. PubMed ID: 31623886 [TBL] [Abstract][Full Text] [Related]
23. Characterization of the CACNA1C-R518C Missense Mutation in the Pathobiology of Long-QT Syndrome Using Human Induced Pluripotent Stem Cell Cardiomyocytes Shows Action Potential Prolongation and L-Type Calcium Channel Perturbation. Estes SI; Ye D; Zhou W; Dotzler SM; Tester DJ; Bos JM; Kim CSJ; Ackerman MJ Circ Genom Precis Med; 2019 Aug; 12(8):e002534. PubMed ID: 31430211 [TBL] [Abstract][Full Text] [Related]
24. Empagliflozin and Dapagliflozin Increase Na Dago M; Crespo-García T; Cámara-Checa A; Rapún J; Rubio-Alarcón M; Marín M; Tamargo J; Caballero R; Delpón E Cells; 2022 Nov; 11(23):. PubMed ID: 36496967 [TBL] [Abstract][Full Text] [Related]
25. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system. Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713 [TBL] [Abstract][Full Text] [Related]
27. Identification of an I Ma D; Liu Z; Loh LJ; Zhao Y; Li G; Liew R; Islam O; Wu J; Chung YY; Teo WS; Ching CK; Tan BY; Chong D; Ho KL; Lim P; Yong RYY; Panama BK; Kaplan AD; Bett GCL; Ware J; Bezzina CR; Verkerk AO; Cook SA; Rasmusson RL; Wei H Sci Rep; 2018 Jul; 8(1):11246. PubMed ID: 30050137 [TBL] [Abstract][Full Text] [Related]
28. Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1. Lan H; Xu Q; El-Battrawy I; Zhong R; Li X; Lang S; Cyganek L; Borggrefe M; Zhou X; Akin I Front Pharmacol; 2020; 11():554422. PubMed ID: 33154722 [TBL] [Abstract][Full Text] [Related]
29. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation. Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes. Lee S; Lee HA; Choi SW; Kim SJ; Kim KS Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276 [TBL] [Abstract][Full Text] [Related]
32. Caveolin-3 Microdomain: Arrhythmia Implications for Potassium Inward Rectifier and Cardiac Sodium Channel. Vaidyanathan R; Reilly L; Eckhardt LL Front Physiol; 2018; 9():1548. PubMed ID: 30473666 [TBL] [Abstract][Full Text] [Related]
33. IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes. Vaidyanathan R; Markandeya YS; Kamp TJ; Makielski JC; January CT; Eckhardt LL Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1611-21. PubMed ID: 27059077 [TBL] [Abstract][Full Text] [Related]
34. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells. Van de Sande DV; Kopljar I; Maaike A; Teisman A; Gallacher DJ; Bart L; Snyders DJ; Leybaert L; Lu HR; Labro AJ Channels (Austin); 2021 Dec; 15(1):239-252. PubMed ID: 33465001 [TBL] [Abstract][Full Text] [Related]
35. Modeling Reentry in the Short QT Syndrome With Human-Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets. Shinnawi R; Shaheen N; Huber I; Shiti A; Arbel G; Gepstein A; Ballan N; Setter N; Tijsen AJ; Borggrefe M; Gepstein L J Am Coll Cardiol; 2019 May; 73(18):2310-2324. PubMed ID: 31072576 [TBL] [Abstract][Full Text] [Related]
36. Repolarization instability and arrhythmia by IKr block in single human-induced pluripotent stem cell-derived cardiomyocytes and 2D monolayers. Altrocchi C; de Korte T; Bernardi J; Spätjens RLHMG; Braam SR; Heijman J; Zaza A; Volders PGA Europace; 2020 Sep; 22(9):1431-1441. PubMed ID: 32770183 [TBL] [Abstract][Full Text] [Related]
37. Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes. Rocchetti M; Sala L; Dreizehnter L; Crotti L; Sinnecker D; Mura M; Pane LS; Altomare C; Torre E; Mostacciuolo G; Severi S; Porta A; De Ferrari GM; George AL; Schwartz PJ; Gnecchi M; Moretti A; Zaza A Cardiovasc Res; 2017 Apr; 113(5):531-541. PubMed ID: 28158429 [TBL] [Abstract][Full Text] [Related]
38. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block. Paci M; Hyttinen J; Rodriguez B; Severi S Br J Pharmacol; 2015 Nov; 172(21):5147-60. PubMed ID: 26276951 [TBL] [Abstract][Full Text] [Related]
39. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes. Schmid C; Abi-Gerges N; Leitner MG; Zellner D; Rast G Cells; 2021 Nov; 10(12):. PubMed ID: 34943878 [TBL] [Abstract][Full Text] [Related]
40. Transcriptome and open chromatin analysis reveals the process of myocardial cell development and key pathogenic target proteins in Long QT syndrome type 7. Chen P; Long J; Hua T; Zheng Z; Xiao Y; Chen L; Yu K; Wu W; Zhang S J Transl Med; 2024 Mar; 22(1):307. PubMed ID: 38528561 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]